Sheryl Skolnick, Mizuho director of research and senior health-care analyst, and Vishnu Lekraj, senior health-care analyst at Morningstar, debate which health-care stocks investors should look at amid uncertainty over Obamacare. » Read More
Dr. Toby Cosgrove, Cleveland Clinic CEO & president, discusses why block grants in the Graham-Cassidy bill would hurt states getting proper funding for health care. » Read More
By: Andrew Zaleski, special to CNBC.com
New visual tools, like eSight3 glasses, help the visually impaired see using HD cameras and video displays placed on the wearer's eyes. » Read More
At least 30-percent of depressed patients don't respond to any of the current drugs on the market. Scientists are hopeful these party drugs may help. » Read More
In the 2017-18 rankings, 82 hospitals ranked among the top 50 in at least one specialty, U.S. News reports.
More than two-thirds of patients can't fully pay hospital bills that are $500 or less, according to a study from TransUnion.
Sheryl Skolnick, Mizuho Securities, and Chris Meekins, FBR, weigh in on health-care stocks and the health-care reform bill.
The Republican bill threads the needle on the industry's concerns, by funding subsidies near-term, and pushing out deep cuts to Medicaid.
Health and hospital stocks released "pent-up demand" after the Senate health bill was unveiled.
Bill Hoagland, Bipartisan Policy Center Health Policy Analyst, discusses the proposed GOP health bill and how the changes will impact the market.
The “Fast Money Halftime Report” traders discuss health-care stocks after the GOP released their health-care bill to the public.
Doctors are using new technologies to help boost organ transplant surgeries in the US that are now at a record high.
Junior doctors in the U.K. are set to strike next month, which could see thousands of operations and appointments delayed or canceled.
A firefighter who had his face badly burned in 2001 now has the face of a Brooklyn bike mechanic.
A help wanted ad by Interim Healthcare is sparking outrage for discriminating against Haitians.
The "Halftime Report" traders give three under-the-radar trades for the second half of the day.
Shire, the specialty pharma company, may need to find an antidote for a poison pill before it can win shareholders in Baxalta over to its $30bn bid.
Innovation has always been the blood pumping through the body of the pharma industry, but in recent years the supply seemed to be getting poorer.
The federal government says health care facilities should stop using Hospira's Symbiq medication infusion pump because its vulnerable to hacking.
Ebola briefly returned to the headlines this week with a scare at a hospital in New York, but the deadly virus continues to claim victims in West Africa.
A man bitten by a rattlesnake this month says he received a $153,000 hospital bill.
As sports grapples with the effects of injuries, one area of medicine is looking to make pain and recovery a thing of the past.
Hospitals are taking on Yelp with their own ratings and review system.
GE Vice Chairman John Rice says public private partnerships can help provide solutions to today's toughest health-care challenges.
Get the best of CNBC in your inbox